January 07, 2025

Patient Insights on HRQOL in Chronic GVHD

Explore how cutaneous graft-versus-host disease impacts patients’ quality of life across physical, psychological, and social domains.

Conexiant

January 07, 2025

Do Probiotics Impact Cancer Survival?

Moderate intake of dietary probiotics was inversely associated with cancer mortality,’ highlighting dose-specific effects seen in a 20-year NHANES analysis.

Conexiant

January 07, 2025

New Vitiligo Markers Found in Blood, Tissue

"Based upon the expression levels of miR-16, 146a, 19b and 720 in both serum and tissue, these biomarkers can be used as early indicators for vitiligo."

Conexiant

January 07, 2025

Air Pollution’s Role in Autoimmune Risks, Genetic Causal Links

Research examines genetic links between air pollution and autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus.

Conexiant

January 06, 2025

Medical Editors Sound Alarm on Fake Journals

"Particularly vulnerable authors are those who are early in their careers, lack experience and adequate mentorship, and face pressure to publish" — top medical journal editors expose how predatory publishers exploit researchers.

Conexiant

January 02, 2025

Each Cigarette Burns 20 Minutes of Life, Study

A 60-year-old smoker will typically have the health profile of a 70-year-old non-smoker.

Conexiant

December 30, 2024

Nutrafol Safety Signal Emerges in Case Study

A previously healthy 26-year-old developed severe liver injury after using Nutrafol, with a biopsy confirming marked necroinflammatory damage with complete resolution upon discontinuation.

Conexiant

December 23, 2024

Cancer Drug Side Effect Causes Skin Changes

New research reveals that one-third of cancer patients developed red, inflammatory skin lesions before experiencing vitiligo-like depigmentation from immune checkpoint inhibitor therapy, potentially offering clinicians an early warning sign.

Conexiant

December 19, 2024

Comparing CBT Delivery Methods in Atopic Dermatitis

A new study published in JAMA Dermatology reveals that a self-guided online cognitive behavioral therapy program for atopic dermatitis was noninferior to clinician-guided treatment, offering promise for disseminating evidence-based psychological treatment for patients.

Conexiant